心肌弥漫性间质纤维化可预测中度及无症状重度主动脉瓣狭窄患者的结局
这项前瞻性国际多中心队列纳入457例中度或无症状重度主动脉瓣狭窄患者,用心脏磁共振的细胞外容积分数(ECV%)和晚期钆增强评估心肌弥漫性间质纤维化与瘢痕。中位随访5.7年发生83例事件,发生事件者ECV%更高(中位26.3% vs 28.2%,P=0.003),ECV%最高三分位(>28.6%)者结局更差,校正后ECV%与结局独立相关(校正HR 1.05,P=0.039),且在上述参数基础上提供显著增量预后价值(P<0.05)。
要点
- 发生事件者ECV%高于未发生事件者(中位26.3% vs 28.2%,P=0.003)。
- ECV%>28.6%的最高三分位患者结局更差,且在校正后仍与结局独立相关(校正HR 1.05,P=0.039)。
- ECV%在主动脉瓣狭窄严重度、心功能、合并症、主动脉瓣置换及LGE基础上提供显著增量预后价值(P<0.05)。
核心结论
- 心肌弥漫性间质纤维化增加与中度及无症状重度主动脉瓣狭窄患者的不良结局相关,并有助于识别需要更密切监测不良结局的患者。
研究设计与样本
- 前瞻性、国际、多中心队列,n=457,纳入中度(主动脉瓣面积1.0-1.5 cm2)或无症状重度(主动脉瓣面积≤1.0 cm2且NYHA功能分级I-II级)主动脉瓣狭窄患者,接受心脏磁共振检查,以细胞外容积分数(ECV%)和晚期钆增强(LGE)分析心肌弥漫性间质纤维化与瘢痕,结局为死亡与心力衰竭入院的复合终点。
关键影像表现/征象
- 中位ECV%为26.6%(IQR 24.4%-29.9%),31.5%的患者存在LGE(中位0.8%;IQR 0.1%-1.7%)。
- 主动脉瓣狭窄严重度更高与左心室质量更大和舒张功能障碍相关,但与ECV%或LGE无关。
诊断标准与关键数值
- 发生事件者中位ECV%为26.3%,未发生事件者中位ECV%为28.2%(P=0.003)。
- ECV%最高三分位为ECV%>28.6%,该组在整个队列以及NYHA功能I级的中度或重度主动脉瓣狭窄患者中结局均更差。
- ECV%与结局独立相关,校正HR为1.05(P=0.039)。
- ECV%加入主动脉瓣狭窄严重度与心功能参数、合并症、主动脉瓣置换及LGE后具有显著增量预后价值(P<0.05)。
临床应用与阅片要点
- 在评估中度或无症状重度主动脉瓣狭窄患者时,可结合心脏磁共振测量的ECV%评估心肌弥漫性间质纤维化,以辅助识别不良结局风险较高的患者。
- ECV%>28.6%的最高三分位与更差结局相关,可提示对此类患者进行更密切的监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Patients with moderate or asymptomatic severe aortic stenosis (AS) are at risk of cardiovascular events.
OBJECTIVES: The authors investigated the utility of cardiac magnetic resonance (CMR) to identify drivers of outcome in patients with moderate or asymptomatic severe AS.
METHODS: A prospective, international, multicenter cohort (n = 457) of patients with moderate (aortic valve area [AVA]: 1.0-1.5 cm2) or asymptomatic severe AS (AVA ≤1.0 cm2 and NYHA functional class I-II) patients underwent CMR. Diffuse interstitial fibrosis and scar in the myocardium were analyzed with extracellular volume fraction (ECV%) and late gadolinium enhancement (LGE). The outcome was a composite of mortality and heart failure admission.
RESULTS: Median ECV% was 26.6% (IQR: 24.4%-29.9%), and LGE was present in 31.5% (median 0.8%; IQR: 0.1%-1.7%). Greater AS severity was associated with greater left ventricular mass and diastolic dysfunction, but not with ECV% or LGE. During a median 5.7 years of follow-up, 83 events occurred. Patients with events had higher ECV% (median ECV% 26.3% vs 28.2%; P = 0.003). Patients in the highest ECV% tertiles (ECV% >28.6%) had worse outcomes both in the entire cohort and in those with NYHA functional class I moderate or severe AS, and ECV% was independently associated with outcome (adjusted HR: 1.05; P = 0.039). The ECV% had significant incremental prognostic value when added to parameters of AS severity and cardiac function, comorbidities, aortic valve replacement, and LGE (P < 0.05).
CONCLUSIONS: Increased diffuse interstitial fibrosis of the myocardium is associated with poor outcomes in patients with moderate and asymptomatic severe AS and can help identify those who require closer surveillance for adverse outcomes.
引用
- Lee HJ, Singh A, Lim J, et al. Diffuse Interstitial Fibrosis of the Myocardium Predicts Outcome in Moderate and Asymptomatic Severe Aortic Stenosis. JACC Cardiovasc Imaging. 2024. PMID: 39340492. doi:10.1016/j.jcmg.2024.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。